| Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action B Ganter, S Tugendreich, CI Pearson, E Ayanoglu, S Baumhueter, ... Journal of biotechnology 119 (3), 219-244, 2005 | 327 | 2005 |
| Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix® database B Ganter, RD Snyder, DN Halbert, MD Lee Future Medicine Ltd 7 (7), 1025-1044, 2006 | 144 | 2006 |
| Pathway analysis tools and toxicogenomics reference databases for risk assessment B Ganter, N Zidek, PR Hewitt, D Müller, A Vladimirova Future Medicine Ltd 9 (1), 35-54, 2008 | 67 | 2008 |
| Emerging applications of network and pathway analysis in drug discovery and development. B Ganter, CN Giroux Current opinion in drug discovery & development 11 (1), 86-94, 2008 | 67 | 2008 |
| Use of a mixed tissue RNA design for performance assessments on multiple microarray formats KL Thompson, BA Rosenzweig, PS Pine, J Retief, Y Turpaz, CA Afshari, ... Nucleic acids research 33 (22), e187-e187, 2005 | 38 | 2005 |
| Use of diagnostic accuracy as a metric for evaluating laboratory proficiency with microarray assays using mixed-tissue RNA reference samples PS Pine, M Boedigheimer, BA Rosenzweig, Y Turpaz, YD He, ... Future Medicine Ltd 9 (11), 1753-1763, 2008 | 15 | 2008 |
| Application of toxicity and biomarker workflows within ingenuity pathways analysis (IPA) results in efficient evaluation of compound toxicity and safety B Ganter, DL Abramovitz Toxicology Letters, S45, 2007 | 3 | 2007 |
| Key aspects of toxicogenomic data analysis and interpretation as a safety assessment tool to identify and understand drug-induced toxicity A Vladimirova, B Ganter Toxicogenomics, 111, 2008 | 1 | 2008 |
| Toxicogenomics for compound selection M Laurance, B Ganter GENETIC ENGINEERING & BIOTECHNOLOGY NEWS 27 (10), 25-25, 2007 | | 2007 |
| Chemogenomics analysis reveals potential molecular mechanism of the drug-drug interaction between statins and fibrates MD Lee, B Ganter, K Jarnagin, DN Halbert The FASEB Journal 21 (5), A416-A416, 2007 | | 2007 |
| Inexpensive and automated predictive and mechanistic analysis of compound effects in vivo and in vitro using microarrays for discovery, lead optimization and preclinical safety … J Retief, G Natsoulis, A Tolley, B Ganter, R Brennan, M Fielden, ... Toxicology Letters, S156-S157, 2006 | | 2006 |
| Discovery of septicaemia-related genes using cDNA microarrays B Ganter, J Libby Nature Genetics 23 (3s), 46, 1999 | | 1999 |
